|
SG11202011133VA
|
|
Systems and methods for pre-analytical substrate processing
|
|
KR20210003287A
|
|
Automated sample preparation system and its applications
|
|
AR115605A1
|
|
SYSTEMS AND METHODS FOR THE PRE-ANALYTICAL PROCESSING OF SUBSTRATES
|
|
US2020165686A1
|
|
DNA Methylation and Mutational Analysis Methods for Bladder Cancer Surveillance
|
|
SG10201912097QA
|
|
Algorithms and methods for assessing late clinical endpoints in prostate cancer
|
|
AU2015230746A1
|
|
Prediction of likelihood of cancer recurrence
|
|
AU2015227398A1
|
|
Method for using gene expression to determine prognosis of prostate cancer
|
|
AU2015202326A1
|
|
Gene expression markers for breast cancer prognosis
|
|
AU2015202116A1
|
|
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
|
US2015299771A1
|
|
Methods for depleting RNA from nucleic acid samples
|
|
EP3063689A1
|
|
Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence risk
|
|
US2016048632A1
|
|
Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer
|
|
WO2014130617A1
|
|
Method of predicting breast cancer prognosis
|
|
WO2014130444A1
|
|
Method of predicting breast cancer prognosis
|
|
US2015302143A1
|
|
Gene fusions and alternatively spliced junctions associated with breast cancer
|
|
US2013274127A1
|
|
Gene expression markers for prediction of response to phosphoinositide 3-kinase inhibitors
|
|
WO2013130465A2
|
|
Gene expression markers for prediction of efficacy of platinum-based chemotherapy drugs
|
|
AU2013200984A1
|
|
Gene expression markers for colorectal cancer prognosis
|
|
AU2013200793A1
|
|
Prediction of likelihood of cancer recurrence
|
|
US2013196321A1
|
|
Gene expression profile algorithm and test for determining prognosis of prostate cancer
|
